stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Operating cash flow
Calumet, Inc.'s operating cash flow for fiscal 2025 was $108.9M, compared with −$46.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was $146.1M. Over the past ten years it has ranged from −$46.4M (fiscal 2024) to $376.4M (fiscal 2015); the current reading is higher than 82% of that period. Calumet, Inc. ranks 33rd of 59 Specialty Chemicals companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $108.9M | — |
| FY2024 | −$46.4M | — |
| FY2023 | −$14.9M | — |
| FY2022 | $100.6M | — |
| FY2021 | −$44.0M | — |
| FY2020 | $62.8M | (67.27%) |
| FY2019 | $191.9M | 155.19% |
| FY2018 | $75.2M | — |
| FY2017 | −$26.5M | — |
| FY2016 | $4.1M | (98.91%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $92.3M | — |
| Mar 2026 | −$86.2M | — |
| Dec 2025 | $116.5M | 395.74% |
| Sep 2025 | $23.5M | — |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| CBT Cabot Corporation compare | $421.0M |
| ASH Ashland Inc. compare | $385.0M |
| AVNT Avient Corporation compare | $347.8M |
| FUL H. B. Fuller Company compare | $289.4M |
| HWKN Hawkins, Inc. compare | $148.8M |
| CLMT Calumet, Inc. | $146.1M |
| SXT Sensient Technologies Corporation compare | $119.9M |
| WDFC WD-40 Company compare | $105.0M |
| PRM Perimeter Solutions, SA compare | $92.1M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement